Personal information

Other IDs

Scopus Author ID: 26868102600

Countries

Cuba

Activities

Collapse all

Employment (3)

Centro para el Control Estatal de Medicamentos Equipos y Dispositivos Médicos: La Habana, La Habana, CU

2019-06 to present | Principal (Innovation Office)
Employment
Source: Self-asserted source
Belkis Romeu

Instituto Finlay: La Habana, La Habana, CU

2018-10 to present | Adviser (Business Department)
Employment
Source: Self-asserted source
Belkis Romeu

WHO: Geneva, Geneva, CH

2014-03-08 to 2018-07-20 | Health Attaché (Cuban Mission Geneva)
Employment
Source: Self-asserted source
Belkis Romeu

Education and qualifications (6)

Graduate Institute of International and Development Studies: Geneva, CH

2016 to 2016 | Executive Course Health Diplomacy and Stakeholders (Health Diplomacy)
Education
Source: Self-asserted source
Belkis Romeu

Graduate Institute of International and Development Studies: Geneva, CH

2015-09 to 2015-09 | Executive Course Humanitarian and Emergency Diplomacy (Health Diplomacy)
Education
Source: Self-asserted source
Belkis Romeu

Graduate Institute of International and Development Studies: Geneva, CH

2014-06 to 2014-07 | Executive Course Health Diplomacy (Health Diplomacy)
Qualification
Source: Self-asserted source
Belkis Romeu

Harvard University: Cambridge, Massachusetts, US

2013-09 to 2014-02 | PhD postdoc (Boston Children Hospital)
Qualification
Source: Self-asserted source
Belkis Romeu

Instituto Finlay: La Habana, La Habana, CU

2000-09-01 to 2014-02-01 | Reasearcher (Immunology Department)
Qualification
Source: Self-asserted source
Belkis Romeu

Instituto Finlay: La Habana, La Habana, CU

2010-10 to 2013-05 | PhD (Immunology Department)
Education
Source: Self-asserted source
Belkis Romeu

Professional activities (1)

Cuban Society of Immunology: La Habana, La Habana, CU

2005 to present | Member
Membership
Source: Self-asserted source
Belkis Romeu

Works (22)

The Role of Regulatory Sciences from the Perspective of the Cuban Medicines Regulatory Agency: The Impact of COVID-19 in Promoting Innovation, Cooperation and Scientific Thinking

Therapeutic Innovation & Regulatory Science
2021-09-03 | Journal article
DOI: 10.1007/s43441-021-00300-0
Contributors: Belkis Romeu; Yaquelín Rodríguez; Silvia Bendiner
Source: check_circle
Crossref

The CECMED Office of Innovation: A Core Initiative to Bolster Novel Pharmaceutical Products-The Cuban Approach

Therapeutic Innovation & Regulatory Science
2021-01-27 | Journal article
DOI: 10.1007/s43441-020-00202-7
Contributors: Belkis Romeu; Rafael Perez Cristiá
Source: check_circle
Crossref

El enfoque regulador en la respuesta cubana contra la COVID-19

Revista Cubana de Farmacia
2020-09 | Journal article
Source: Self-asserted source
Belkis Romeu

Concertation a practical tool to address global health problems, including vaccine-preventable diseases

Vaccimonitor
2019 | Preprint
DOI: DOI: 10.13140/RG.2.2.31931.05923
Source: Self-asserted source
Belkis Romeu

Cuban health diplomacy: Focused on international cooperation. A comment on Chattu et al.

Journal of Education and Health Promotion
2019-10 | Journal article
Source: Self-asserted source
Belkis Romeu

Oficina de Innovación: nuevo desafío del CECMED

Editorial Anuario Científico 2019
2019-08 | Journal article
DOI: 10.20944/preprints201909.0204.v1
Source: Self-asserted source
Belkis Romeu
grade
Preferred source (of 3)‎

Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii

International Immunopharmacology
2016 | Journal article
DOI: 10.1016/j.intimp.2016.09.008
EID:

2-s2.0-84988025265
Contributors: Batista-Duharte, A.; Lastre, M.; Romeu, B.; Portuondo, D.L.; Téllez-Martínez, D.; Manente, F.A.; Pérez, O.; Carlos, I.Z.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Mucosal and systemic immune responses induced by a single time vaccination strategy in mice

Canadian Journal of Microbiology
2015 | Journal article
DOI: 10.1139/cjm-2015-0063
EID:

2-s2.0-84938517949
Contributors: Aznar, E.G.; Romeu, B.; Lastre, M.; Zayas, C.; Cuello, M.; Cabrera, O.; Valdez, Y.; Fariñas, M.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A

Immunologic Research
2014 | Journal article
DOI: 10.1007/s12026-013-8427-6
EID:

2-s2.0-84893737367
Contributors: Romeu, B.; Lastre, M.; García, L.; Cedré, B.; Mandariote, A.; Fariñas, M.; Oliva, R.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Erratum to: Combined meningococcal serogroup A and W<inf>135</inf> outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A (Immunol Res, DOI 10.1007/s12026-013-8427-6)

Immunologic Research
2014 | Journal article
DOI: 10.1007/s12026-013-8431-x
EID:

2-s2.0-84957430033
Contributors: Romeu, B.; Lastre, M.; García, L.; Cedré, B.; Mandariote, A.; Fariñas, M.; Oliva, R.; Rosenqvist, E.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Immune-Potentiators for the aquaculture,Inmunopotenciadores para la acuicultura

VacciMonitor
2014 | Journal article
EID:

2-s2.0-84898855708
Contributors: Pérez, R.; Romeu, B.; Lastre, M.; Morales, Y.; Cabrera, O.; Reyes, L.; González, E.; Sifontes, S.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses

Vaccine
2014 | Journal article
DOI: 10.1016/j.vaccine.2014.10.037
EID:

2-s2.0-84924162009
Contributors: Romeu, B.; Lastre, M.; Reyes, L.; González, E.; Borrero, Y.; Lescaille, D.; Pérez, R.; Nuñez, D.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier
grade
Preferred source (of 2)‎

Adjuvants are key factors for the development of future vaccines: Lessons from the Finlay adjuvant platform

Frontiers in Immunology
2013 | Journal article
DOI: 10.3389/fimmu.2013.00407
EID:

2-s2.0-84892144204
Contributors: Pérez, O.; Romeu, B.; Cabrera, O.; González, E.; Batista-Duharte, A.; Labrada, A.; Pérez, R.; Reyes, L.M.; Ramírez, W.; Sifontes, S. et al.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.

BMC immunology
2013 | Other
EID:

2-s2.0-84882598407
Contributors: Zayas, C.; González, D.; Acevedo, R.; del Campo, J.; Lastre, M.; González, E.; Romeu, B.; Cuello, M.; Balboa, J.; Cabrera, O. et al.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens

Journal of Drug Targeting
2012 | Journal article
DOI: 10.3109/1061186X.2012.693497
EID:

2-s2.0-84861809317
Contributors: Romeu, B.; Gonzalez, E.; Lastre, M.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

In vitro study of protein release from AFCo1 and implications in mucosal immunisation,Estudio in vitro de liberación de proteínas de AFCo1 y sus implicaciones en la inmunización mucosal

VacciMonitor
2012 | Journal article
EID:

2-s2.0-84864845006
Contributors: Acevedo, R.; Romeu, B.; Zayas, C.; González, E.; Lastre, M.; del Campo, J.; Mullen, A.; Ferro, V.A.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses

Scandinavian Journal of Infectious Diseases
2011 | Journal article
DOI: 10.3109/00365548.2011.586648
EID:

2-s2.0-80052493229
Contributors: Romeu, B.; González, E.; Zayas, C.; Campo, J.D.; Acevedo, R.; Cuello, M.; Valdes, Y.; Balboa, J.; Cabrera, O.; Lastre, M. et al.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1

Canadian Journal of Microbiology
2011 | Journal article
DOI: 10.1139/W11-002
EID:

2-s2.0-79952209563
Contributors: Romeu, B.; González, E.; del Campo, J.; Acevedo, R.; Zayas, C.; Valdés, Y.; Cabrera, O.; Cuello, M.; Balboa, J.; Lastre, M. et al.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

The golden era of vaccine adjuvants

Expert Review of Vaccines
2011 | Journal article
DOI: 10.1586/erv.11.62
EID:

2-s2.0-80051533519
Contributors: Cabrera, O.; Cuello, M.; Lastre, M.; Romeu, B.; Balboa, J.; Zayas, C.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

2nd International Workshop on Neisseria vaccines (Neisseria vaccines 2009): Varadero, Matanzas, Cuba, 17-22 May 2009

Expert Review of Vaccines
2009 | Journal article
DOI: 10.1586/erv.09.71
EID:

2-s2.0-68049126091
Contributors: Romeu, B.; González, E.; Campa, C.; Holst, J.; Pérez, O.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice

Methods
2009 | Journal article
DOI: 10.1016/j.ymeth.2009.03.027
EID:

2-s2.0-70350726779
Contributors: Acevedo, R.; Callicó, A.; del Campo, J.; González, E.; Cedré, B.; González, L.; Romeu, B.; Zayas, C.; Lastre, M.; Fernández, S. et al.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses

Methods
2009 | Journal article
DOI: 10.1016/j.ymeth.2009.03.025
EID:

2-s2.0-70350712778
Contributors: Campo, J.d.; Zayas, C.; Romeu, B.; Acevedo, R.; González, E.; Bracho, G.; Cuello, M.; Cabrera, O.; Balboa, J.; Lastre, M.
Source: Self-asserted source
Belkis Romeu via Scopus - Elsevier
How many people are using ORCID?